Literature DB >> 30097741

Quantitative 19F MRI of perfluoro-15-crown-5-ether using uniformity correction of the spin excitation and signal reception.

Ina Vernikouskaya1,2, Alexander Pochert3, Mika Lindén3, Volker Rasche4,5.   

Abstract

OBJECTIVES: A common limitation of all 1H contrast agents is that they only allow indirect visualization through modification of the intrinsic properties of the tissue, making quantification of this effect challenging. 19F compounds, on the contrary, are measured directly, without any background signal. There is a linear relationship between the amount of 19F spins and the intensity of the signal. However, non-uniformity of the radiofrequency field may lead to errors in the quantified 19F signal and should be carefully addressed for any quantitative imaging.
MATERIALS AND METHODS: Adaptation of the previously introduced [Formula: see text] mapping technique to the problem of quantifying the 19F signal from perfluoro-15-crown-5-ether (PFCE) is proposed in this work. Initial evaluation of the proposed technique simultaneously accounting for transmit [Formula: see text] and receive [Formula: see text] field inhomogeneities is performed in a PFCE phantom. As a proof of concept, in vivo quantification of the 19F signal is performed in a murine model after application of custom-designed hollow mesoporous silica spheres (HMSS) loaded with PFCE.
RESULTS: A phantom experiment clearly shows that only compensation for both transmit and receive characteristics outperforms inaccurate quantification based on the non- or partly-corrected signal intensities. Furthermore, an optimized protocol is proposed for in vivo application.
CONCLUSION: The proposed [Formula: see text]/[Formula: see text] mapping technique represents a simple to implement and easy-to-use solution for quantification of the 19F signal from PFCE in the presence of B1-field inhomogeneities.

Entities:  

Keywords:  19F MRI; B 1 inhomogeneity; Hollow mesoporous silica spheres; Perfluoro-15-crown-5-ether; Quantification

Mesh:

Substances:

Year:  2018        PMID: 30097741     DOI: 10.1007/s10334-018-0696-6

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  6 in total

1.  Special issue on fluorine-19 magnetic resonance: technical solutions, research promises and frontier applications.

Authors:  Sonia Waiczies; Mangala Srinivas; Ulrich Flögel; Philipp Boehm-Sturm; Thoralf Niendorf
Journal:  MAGMA       Date:  2019-02       Impact factor: 2.310

2.  Protein-Engineered Nanoscale Micelles for Dynamic 19F Magnetic Resonance and Therapeutic Drug Delivery.

Authors:  Lindsay K Hill; Joseph A Frezzo; Priya Katyal; Dung Minh Hoang; Zakia Ben Youss Gironda; Cynthia Xu; Xuan Xie; Erika Delgado-Fukushima; Youssef Z Wadghiri; Jin Kim Montclare
Journal:  ACS Nano       Date:  2019-02-19       Impact factor: 15.881

3.  From In Vitro to Perioperative Vascular Tissue Engineering: Shortening Production Time by Traceable Textile-Reinforcement.

Authors:  Saurav Ranjan Mohapatra; Elena Rama; Christoph Melcher; Tobias Call; Miriam Aischa Al Enezy-Ulbrich; Andrij Pich; Christian Apel; Fabian Kiessling; Stefan Jockenhoevel
Journal:  Tissue Eng Regen Med       Date:  2022-10-06       Impact factor: 4.451

Review 4.  19 F MRI Nanotheranostics for Cancer Management: Progress and Prospects.

Authors:  Yanan Li; Jing Cui; Chenlong Li; Huimin Zhou; Jun Chang; Omer Aras; Feifei An
Journal:  ChemMedChem       Date:  2022-01-12       Impact factor: 3.540

5.  The sensitivity of magnetic particle imaging and fluorine-19 magnetic resonance imaging for cell tracking.

Authors:  Olivia C Sehl; Paula J Foster
Journal:  Sci Rep       Date:  2021-11-12       Impact factor: 4.379

6.  Ultra-high-frequency radio-frequency acoustic molecular imaging with saline nanodroplets in living subjects.

Authors:  Yun-Sheng Chen; Yang Zhao; Corinne Beinat; Aimen Zlitni; En-Chi Hsu; Dong-Hua Chen; Friso Achterberg; Hanwei Wang; Tanya Stoyanova; Jennifer Dionne; Sanjiv Sam Gambhir
Journal:  Nat Nanotechnol       Date:  2021-03-29       Impact factor: 40.523

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.